The effectiveness of new hormone therapy treatments on progression-free survival of patients with HR+/HER2- metastatic breast cancer: a systematic review. RSD [Internet]. 2021 Oct. 26 [cited 2025 Dec. 5];10(14):e85101421940. Available from: https://rsdjournal.org/rsd/article/view/21940